PubAg

Main content area

Extracts from Sageretia thea reduce cell viability through inducing cyclin D1 proteasomal degradation and HO-1 expression in human colorectal cancer cells

Author:
Kim, Ha Na, Park, Gwang Hun, Park, Su Bin, Kim, Jeong Dong, Eo, Hyun Ji, Son, Ho-Jun, Song, Jeong Ho, Jeong, Jin Boo
Source:
BMC complementary and alternative medicine 2019 v.19 no.1 pp. 43
ISSN:
1472-6882
Subject:
D1 protein, Sageretia thea, Western blotting, antineoplastic activity, antineoplastic agents, apoptosis, branches, cell viability, colorectal neoplasms, cyclins, gene expression, hepatitis, humans, leaves, medicinal plants, messenger RNA, neoplasm cells, phosphorylation, physiological transport, reverse transcriptase polymerase chain reaction, tau-protein kinase, toxicity testing, China, Korean Peninsula
Abstract:
BACKGROUND: Sageretia thea (S. thea) has been used as the medicinal plant for treating hepatitis and fevers in Korea and China. Recently, anticancer activity of S. thea has been reported, but the potential mechanism for the anti-cancer property of S. thea is still insufficient. Thus, we evaluated whether extracts from the leaves (STL) and branches (STB) of S. thea exert anticancer activity and elucidated its potential mechanism in SW480 cells. METHODS: MTT assay was performed for measuring cell viability. Western blot and RT-PCR were used for analyzing the level of protein and mRNA, respectively. RESULTS: Treatment of STL or STB decreased the cell viability and induced apoptosis in SW480 cells. Decreased level of cyclin D1 protein was observed in SW480 cells treated with STL or STB, but no change in cyclin D1 mRNA level was observed with the treatment of STL or STB. MG132 blocked downregulation of cyclin D1 protein by STL or STB. Thr286 phosphorylation of cyclin D1 by STL or STB occurred faster than downregulation of cyclin D1 protein in SW480 cells. When SW480 cells were transfected with T286A-cyclin D1, cyclin D1 degradation by STL or STB did not occur. Inhibition of GSK3β and cyclin D1 nuclear export attenuated STL or STB-mediated cyclin D1 degradation. In addition, STL or STB increased HO-1 expression, and the inhibition of HO-1 attenuated the induction of apoptosis by STL or STB. HO-1 expression by STL or STB resulted from Nrf2 activation through ROS-dependent p38 activation. CONCLUSIONS: These results indicate that STL or STB may induce GSK3β-dependent cyclin D1 degradation, and increase HO-1 expression through activating Nrf2 via ROS-dependent p38 activation, which resulted in the decrease of the viability in SW480 cells. These findings suggest that STL or STB may have great potential for the development of anti-cancer drug.
Agid:
6305348